Qyuns Therapeutics Co., Ltd. Class H · HKEX:2509

Qyuns Therapeutics Co., Ltd. Class H financial statements

Qyuns Therapeutics Co., Ltd. Class H's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue786.1M158.8M14.8M9.66M21.3M
Cost of revenue121.4M66.6M35.7M35.5M30.9M
Gross profit664.7M92.2M-33.0M9.66M-9.56M
Research and development239.2M334.3M364.4M257.2M151.9M
Selling, general and administrative99.8M115.9M164.6M76.6M24.0M
Operating income319.7M-326.4M-504.5M-293.7M-168.6M
Depreciation and amortization32.1M32.7M32.3M30.5M25.6M
EBITDA351.8M-293.7M-472.2M-263.1M-143.0M
Interest expense21.6M23.4M16.8M18.7M17.8M
Income before tax299.4M-349.8M-521.3M-312.4M-426.5M
Income tax71.1K-73.0K-73.0K-73.0K-73.0K
Net income306.3M-335.6M-507.7M-298.2M-411.0M
Earnings per share, basic1.37-1.53-2.47-1.34-1.85

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents962.2M360.7M216.3M213.1M218.1M
Short-term investments80.3M195.4M160.4M450.3M402.4M
Receivables19.9M26.9M364.0K662.0K354.0K
Inventory38.1M3.34M3.77M0
Current assets1.12B616.7M418.3M714.0M648.3M
Property, plant and equipment334.1M363.2M389.0M
Total assets1.60B983.9M795.6M1.16B1.07B
Accounts payable96.8M110.9M73.0M19.1M12.6M
Current liabilities504.0M430.2M251.8M122.2M69.7M
Long-term debt399.4M315.1M224.4M232.5M274.0M
Total debt580.3M527.6M346.1M295.3M290.3M
Total liabilities921.6M762.8M494.6M373.7M363.3M
Shareholders' equity694.3M229.0M294.8M641.7M670.4M
Shares outstanding223.7M219.4M205.7M222.1M222.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations399.8M-186.1M-300.7M-225.2M-122.6M
Capital spending-7.62M-1.76M-7.95M-26.5M-71.0M
Free cash flow392.2M-187.9M-308.6M-301.7M-228.6M
Cash from investing118.7M-25.2M243.1M-5.70M-247.4M
Cash from financing93.7M351.8M61.2M211.5M281.5M
Share buybacks-27.2M196.5M29.5M228.0M
Change in cash601.1M144.4M3.21M-4.96M-91.2M